![PDF] A randomized, double-masked clinical trial of Optisol-GS vs Chen Medium for human corneal storage. | Semantic Scholar PDF] A randomized, double-masked clinical trial of Optisol-GS vs Chen Medium for human corneal storage. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/431eecf34087bb702b55c322d8e5e4c8c072398b/4-Table2-1.png)
PDF] A randomized, double-masked clinical trial of Optisol-GS vs Chen Medium for human corneal storage. | Semantic Scholar
![PDF) Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: A randomized double-masked clinical trial | Seyed-Farzad Mohammadi and Hooshang Faghihi - Academia.edu PDF) Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: A randomized double-masked clinical trial | Seyed-Farzad Mohammadi and Hooshang Faghihi - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/31631718/mini_magick20190426-18945-1vial9e.png?1556266942)
PDF) Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: A randomized double-masked clinical trial | Seyed-Farzad Mohammadi and Hooshang Faghihi - Academia.edu
PLOS ONE: Comparative efficacy of two different topical povidone-iodine 5% regimens in reducing conjunctival bacterial flora: A randomized parallel double-masked clinical trial
![A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19 - eClinicalMedicine A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19 - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ad18e4a5-5e20-42d1-8a6c-fab18b625111/gr1.jpg)
A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19 - eClinicalMedicine
![Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials - The Lancet Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e71c5fac-840d-4a72-b42b-ae030142df74/gr1.gif)
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials - The Lancet
![Aldeyra Therapeutics Announces Achievement of Primary Endpoint of Ocular Redness in Randomized, Double-Masked, Vehicle-Controlled Phase 2 Clinical Trial in Dry Eye Disease | Business Wire Aldeyra Therapeutics Announces Achievement of Primary Endpoint of Ocular Redness in Randomized, Double-Masked, Vehicle-Controlled Phase 2 Clinical Trial in Dry Eye Disease | Business Wire](https://mms.businesswire.com/media/20211102005345/en/922307/23/ALDX_logo_JPEG.jpg)
Aldeyra Therapeutics Announces Achievement of Primary Endpoint of Ocular Redness in Randomized, Double-Masked, Vehicle-Controlled Phase 2 Clinical Trial in Dry Eye Disease | Business Wire
![PDF) A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis PDF) A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis](https://i1.rgstatic.net/publication/10985975_A_multicentre_randomised_double_masked_clinical_trial_of_a_new_formulation_of_topical_cysteamine_for_the_treatment_of_corneal_cystine_crystals_in_cystinosis/links/564cce2008aefe619b0d8ef3/largepreview.png)
PDF) A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis
![Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS-CoV-2 Transmission and Exposure, 2021 | MMWR Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS-CoV-2 Transmission and Exposure, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7007e1_DoubleMasksEfficacy_IMAGE_10Feb21_1200x675-medium.jpg?_=60721)
Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS-CoV-2 Transmission and Exposure, 2021 | MMWR
![Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis. - Abstract - Europe PMC Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis. - Abstract - Europe PMC](https://europepmc.org/articles/PMC2095503/bin/bj122044.f1.jpg)
Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis. - Abstract - Europe PMC
![HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration - Ophthalmology HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration - Ophthalmology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/46810730-7a6d-4556-8d77-11f828e94a75/gr1ab_lrg.jpg)
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration - Ophthalmology
![Phase IIIb Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration PIER Study Year 1 Regillo CD, - ppt download Phase IIIb Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration PIER Study Year 1 Regillo CD, - ppt download](https://slideplayer.com/8277312/25/images/slide_1.jpg)
Phase IIIb Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration PIER Study Year 1 Regillo CD, - ppt download
![PDF) A Randomized Double-Masked Clinical Trial Comparing Four Periodontitis Treatment Strategies: 5-Year Tooth Loss Results PDF) A Randomized Double-Masked Clinical Trial Comparing Four Periodontitis Treatment Strategies: 5-Year Tooth Loss Results](https://i1.rgstatic.net/publication/309360542_A_Randomized_Double-Masked_Clinical_Trial_Comparing_Four_Periodontitis_Treatment_Strategies_5-Year_Tooth_Loss_Results/links/581877c208aee7cdc685a246/largepreview.png)